View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Analysis
November 11, 2021updated 11 Jul 2022 2:19pm

North America is seeing a hiring boom in clinical trial operations industry AI roles

The number of roles in North America made up 50.4% of total AI jobs.

By Michael Goodier

North America extended its dominance in artificial intelligence (AI) hiring among clinical trial operations industry companies in the three months ending September.

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

The number of roles in North America made up 50.4 per cent of total AI jobs – up from 44.7 per cent in the same quarter last year.

That was followed by Asia-Pacific, which saw a 0.7 year-on-year percentage point change in AI roles.

The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time. Using textual analysis, these job advertisements are then classified thematically.

GlobalData's thematic approach to sector activity seeks to group key company information by topic to see which companies are best placed to weather the disruptions coming to their industries.

These key themes, which include artificial intelligence, are chosen to cover "any issue that keeps a CEO awake at night".

By tracking them across job advertisements it allows us to see which companies are leading the way on specific issues and which are dragging their heels - and importantly where the market is expanding and contracting.

Which countries are seeing the most growth for AI roles in pharmaceuticals?

The fastest growing country was the United States, which saw 44.7 per cent of all AI job adverts in the three months ending June last year, increasing to 50.4 per cent in the three months ending September this year.

That was followed by Poland (up 2.1 percentage points), France (up 1.3), and India (up 0.8).

The top country for AI roles in the clinical trial operations industry is the United States which saw 50.4 per cent of all roles in the three months ending September.

Which cities are the biggest hubs for AI workers in pharmaceuticals?

Some 4.5 per cent of all clinical trial operations industry AI roles were advertised in Cambridge (United States) in the three months ending September - more than any other city.

That was followed by Cambridge (United Kingdom) with 4.5 per cent, Boston (United States) with 4.1 per cent, and Durham (United States) with 2.5 per cent.

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena